News FDA clears Roche, Lilly Alzheimer's blood test A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer's more quickly has been approved by the FDA.
News Kelun gets world-first approval for TROP2 ADC Kelun-Biotech has picked up another world-first approval for its TROP2-targeting ADC sac-TMT in non-small cell lung cancer.
News Chaos as layoffs start to hit HHS agencies Job losses start at federal agencies, including HHS, but initial reports suggest some workers who have been let go are quickly being reinstated.
News AstraZeneca joins Pfizer in MFN pricing deal with US AstraZeneca has become the second pharma group to reach an agreement with the Trump administration on Most Favoured Nation (MFN) drug pricing.
News AZ starts work on Virginia plant in $50bn US investment plan The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.
News TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales? Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.
News GSK abandons cough drug added in $2bn Bellus deal Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.